Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Summary

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Eligibility

Inclusion Criteria:

* Age ≥ 18 years;
* Diagnosis of type 2 diabetes mellitus (T2DM);
* Ability to understand the study procedures and provide written informed consent.

Exclusion Criteria:

* Known or suspected liver disease;
* Patients with type 1 diabetes mellitus;
* Cardiac surgery or percutaneous coronary revascularization scheduled within the next 3 months;
* Patients with acute inflammatory or infectious diseases during the previous 3 months;
* Patients with chronic inflammatory, immune, or infectious diseases;
* Patients with ongoing malignant neoplasms;
* History of alcohol, drug, or medication abuse;
* Clinically significant hematological disorders;
* Systemic steroid treatment within the last 6 months;
* Acute-phase metabolic disorders;
* Any condition that may put the patient at risk by participating in the study.

Conditions2

Browse More Trials